Protalix Biotherapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $232k | 184k | 1.26 |
| 2023-09-30 | $264k | 159k | 1.66 |
| 2023-06-30 | $318k | 159k | 2.00 |
| 2023-03-31 | $281k | 134k | 2.10 |
| 2022-12-31 | $183k | 134k | 1.37 |
| 2022-09-30 | $139k | 134k | 1.04 |
| 2022-06-30 | $173k | 159k | 1.09 |
| 2022-03-31 | $31k | 29k | 1.08 |
| 2021-09-30 | $78k | 59k | 1.32 |
| 2021-06-30 | $752k | 394k | 1.91 |
| 2021-03-31 | $1.4M | 303k | 4.46 |
| 2020-12-31 | $772k | 213k | 3.63 |
| 2020-09-30 | $823k | 213k | 3.87 |
| 2020-06-30 | $661k | 174k | 3.79 |
| 2020-03-31 | $210k | 90k | 2.35 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management